These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10644301)

  • 1. Proton pump inhibitors for Barrett's oesophagus.
    Triadafilopoulos G
    Gut; 2000 Feb; 46(2):144-6. PubMed ID: 10644301
    [No Abstract]   [Full Text] [Related]  

  • 2. Barrett's oesophagus and proton pump inhibitors: a pathological perspective.
    Shepherd NA
    Gut; 2000 Feb; 46(2):147-9. PubMed ID: 10644302
    [No Abstract]   [Full Text] [Related]  

  • 3. How should Barrett's ulceration be treated?
    Peters JH; Wang KK
    Surg Endosc; 2004 Feb; 18(2):338-44. PubMed ID: 14712389
    [No Abstract]   [Full Text] [Related]  

  • 4. Managing Barrett's oesophagus.
    Hebbard GS; Nandurkar S
    Med J Aust; 2004 Apr; 180(8):375-6. PubMed ID: 15089724
    [No Abstract]   [Full Text] [Related]  

  • 5. The Effect of Proton Pump Inhibitors on Barrett's Esophagus.
    Dunbar KB; Souza RF; Spechler SJ
    Gastroenterol Clin North Am; 2015 Jun; 44(2):415-24. PubMed ID: 26021202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical treatment of Barrett's esophagus.
    Spechler SJ
    J Gastrointest Surg; 2000; 4(2):119-21. PubMed ID: 10885955
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dyspepsia and reflux. Systematic literature review from SBU].
    Von Holstein CS; Norlund A
    Lakartidningen; 2007 May 2-8; 104(18):1414-7. PubMed ID: 17550016
    [No Abstract]   [Full Text] [Related]  

  • 8. Does the treatment of proton pump inhibitors reduce dysplasia or adenocarcinoma development in Barrett's esophagus?
    Akın H; Aydın Y
    Turk J Gastroenterol; 2017 Dec; 28(Suppl 1):S31-S32. PubMed ID: 29199164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ask the doctor. Do PPI drugs for stomach acid reduce the risk of cancer in people (like me) with Barrett's esophagus?
    Komaroff AL
    Harv Health Lett; 2014 Apr; 39(6):2. PubMed ID: 24873004
    [No Abstract]   [Full Text] [Related]  

  • 10. Medical treatment of Barrett's esophagus: can it prevent cancer?
    Sampliner RE
    Surg Oncol Clin N Am; 2009 Jul; 18(3):503-8. PubMed ID: 19500739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
    Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
    Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter: proton pump inhibitor usage still seems to reduce the risk of high-grade dysplasia and/or oesophageal adenocarcinoma in Barrett's oesophagus.
    Aydin Y; Akin H
    Aliment Pharmacol Ther; 2014 Oct; 40(7):859-60. PubMed ID: 25185738
    [No Abstract]   [Full Text] [Related]  

  • 13. Local Synthesis of Pepsin in Barrett's Esophagus and the Role of Pepsin in Esophageal Adenocarcinoma.
    Samuels T; Hoekzema C; Gould J; Goldblatt M; Frelich M; Bosler M; Lee SH; Johnston N
    Ann Otol Rhinol Laryngol; 2015 Nov; 124(11):893-902. PubMed ID: 26077392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From Reflux Esophagitis to Esophageal Adenocarcinoma.
    Souza RF
    Dig Dis; 2016; 34(5):483-90. PubMed ID: 27331918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter: proton pump inhibitor usage still seems to reduce the risk of high-grade dysplasia and/or oesophageal adenocarcinoma in Barrett's oesophagus--authors' reply.
    Hvid-Jensen F; Drewes AM; Funch-Jensen P
    Aliment Pharmacol Ther; 2014 Oct; 40(7):860-1. PubMed ID: 25185739
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison of surgical patients with gastroesophageal reflux disease and Barrett's esophagus].
    Zsolt S; Paszt A; Géczi T; Abrahám S; Tóth I; Horváth Z; Pieler J; Tajti J; Varga A; Tiszlavicz L; Németh I; Izbéki F; Rosztóczy A; Wittmann T; Lázár G
    Magy Seb; 2014 Oct; 67(5):287-96. PubMed ID: 25327403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of risk for Barrett's esophagus and esophageal adenocarcinoma.
    Thrift AP
    Curr Opin Gastroenterol; 2016 Jul; 32(4):319-24. PubMed ID: 27276368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and prevention of oesophageal adenocarcinoma.
    Ness-Jensen E
    Scand J Gastroenterol; 2022 Aug; 57(8):891-895. PubMed ID: 35234549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Acid Suppression in Barrett's Esophagus.
    Elias PS; Castell DO
    Am J Med; 2017 May; 130(5):525-529. PubMed ID: 28159599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barrett's esophagus: A comprehensive review for the internist.
    Klavan H; Russell MB; Macklin J; Lee E; Aslanian HR; Muniraj T
    Dis Mon; 2018 Nov; 64(11):471-487. PubMed ID: 29880269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.